BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34780174)

  • 1. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
    Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
    J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
    Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
    Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3.
    Ozgur C; Doruker P; Akten ED
    BMC Struct Biol; 2016 Jul; 16(1):9. PubMed ID: 27368374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
    Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
    Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
    Bhattacharya S; Hall SE; Li H; Vaidehi N
    Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
    Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation of conformational changes during μ-opioid receptor activation.
    Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
    Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
    Niesen MJ; Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of β
    Ma X; Hu Y; Batebi H; Heng J; Xu J; Liu X; Niu X; Li H; Hildebrand PW; Jin C; Kobilka BK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23096-23105. PubMed ID: 32868434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.
    Miao Y; McCammon JA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12162-12167. PubMed ID: 27791003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β
    Martin C; Moors SLC; Danielsen M; Betti C; Fabris C; Sejer Pedersen D; Pardon E; Peyressatre M; Fehér K; Martins JC; Mosolff Mathiesen J; Morris MC; Devoogdt N; Caveliers V; De Proft F; Steyaert J; Ballet S
    Chemistry; 2017 Jul; 23(40):9632-9640. PubMed ID: 28449310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ligand-specific G protein-coupled receptor states and prediction of downstream efficacy via data-driven modeling.
    Fleetwood O; Carlsson J; Delemotte L
    Elife; 2021 Jan; 10():. PubMed ID: 33506760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDP Release from the Open Conformation of Gα Requires Allosteric Signaling from the Agonist-Bound Human β
    Kumar V; Hoag H; Sader S; Scorese N; Liu H; Wu C
    J Chem Inf Model; 2020 Aug; 60(8):4064-4075. PubMed ID: 32786510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the conformation transition in the activation pathway of β2 adrenergic receptor via a targeted molecular dynamics simulation.
    Xiao X; Zeng X; Yuan Y; Gao N; Guo Y; Pu X; Li M
    Phys Chem Chem Phys; 2015 Jan; 17(4):2512-22. PubMed ID: 25494239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of intracellular allosteric β
    Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
    Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
    DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
    Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.